---
slug: enjektable
name: Injectable
badge: Injection
description: "Injectable form products are administered subcutaneously via syringe and provide rapid effect."
details:
  - "Injectable products provide significant advantages in FIP treatment by providing rapid action, high bioavailability and precise dose control, especially in the critical and early stages of treatment. In severe cases where there is no swallowing reflex, the cat is not eating, or oral intake is not possible, it is an indispensable application form for the continuous, safe and effective continuation of treatment."
images:
  - /assets/source/vial_01.png
  - /assets/source/vial_02.png
heroImage: /assets/source/vial_01.png
dosageCards:
  - weight: "0-1 kg"
    lines:
      - "Daily dose 0.15cc"
      - "Injection course"
      - "1 Vial application period 60 days"
  - weight: "1-2 kg"
    lines:
      - "Daily dose 0.3cc"
      - "Injection course"
      - "1 Vial application period 30 days"
  - weight: "2-3 kg"
    lines:
      - "Daily dose 0.45cc"
      - "Injection course"
      - "1 Vial application period 20 days"
  - weight: "3-4 kg"
    lines:
      - "Daily dose 0.6cc"
      - "Injection course"
      - "1 Vial application period 15 days"
  - weight: "4-5 kg"
    lines:
      - "Daily dose 0.75cc"
      - "Injection course"
      - "1 Vial application period 12 days"
  - weight: "5-6 kg"
    lines:
      - "Daily dose 0.9cc"
      - "Injection course"
      - "1 Vial application period 10 days"
dosageNote: "The minimum treatment period is 90 days. Subcutaneous injection is administered every 24 hours."
priceList:
  - name: "FIPGL23 Injectable Form"
    weight: "2 Pieces"
    unit: "Vial"
    price: "5800 TL"
  - name: "FIPGL23 Injectable Form"
    weight: "4 Pieces"
    unit: "Vial"
    price: "10400 TL"
  - name: "FIPGL23 Injectable Form"
    weight: "6 Pieces"
    unit: "Vial"
    price: "14400 TL"
  - name: "FIPGL23 Injectable Form"
    weight: "8 Pieces"
    unit: "Vial"
    price: "17600 TL"
  - name: "FIPGL23 Injectable Form"
    weight: "10 Pieces"
    unit: "Vial"
    price: "20000 TL"
  - name: "FIPGL23 Injectable Form"
    weight: "12 Pieces"
    unit: "Vial"
    price: "21600 TL"
  - name: "FIPGL23 Injectable Form"
    weight: "1 Piece"
    unit: "Vial"
    price: "2900 TL"
order: 3
---
FIP (Feline Infectious Peritonitis) treatment requires a fast, controlled, and reliable approach, especially in severe and advanced cases. The application form of the product used in this process is critical for the sustainability of treatment.

### Safe use when oral intake is not possible in severe cases
In advanced FIP cases:
* Weakening or loss of the swallowing reflex
* Loss of appetite and not eating
* Resistance to oral medication application
are frequently observed.

ðŸ”¹ In such cases, injectable products allow for the continuous maintenance of treatment without the need for oral intake and offer a vital alternative.

### Effect independent of the gastrointestinal system
Injectable application bypasses the gastrointestinal system:
* Without being affected by vomiting and regurgitation
* Without loss of absorption
* Provides direct participation in the systemic circulation
This feature increases treatment efficacy in severe clinical pictures.

### Rapid and predictable bioavailability
Injectable form:
* Ensures rapid entry of the active substance into the circulation
* Contributes to the earlier observation of clinical response
* Minimizes absorption differences
This advantage is critical, especially in patients with poor general condition.

### Dose control and clinical safety
Injectable products:
* Allow for precise and controlled dose application
* Eliminate the risk of dose loss and irregular intake
* Provide maximum safety under veterinary supervision

### Efficacy in critical and initial periods of treatment
Injectable form provides a significant advantage especially:
* In acute and severe stages of the disease
* In cases where oral medication is not possible
* In cases where treatment needs to be started quickly
